Recon: GSK, Vir seek EUA for COVID antibody; FDA adcomm votes 19-to-1 against Pfizer’s tanezumab

• Biden sets goal of 200 million US COVID-19 shots in his first 100 days (Reuters) (Politico)
• J&J on track to meet vaccine delivery goal, White House says (Politico)
• For Biden, a New Virus Dilemma: How to Handle a Looming Glut of Vaccine (NYTimes)
• ‘Alex Azar Anonymous’: Trump health officials start a club to counter former HHS chief (Politico)
• Autopsy of a pandemic: 6 doctors at the center of the US Covid-19 response (CNN)
• GSK and Vir seek emergency use of COVID-19 therapy in United States (Reuters)
• New study to test Moderna vaccine in transmission prevention among college students (Reuters)
• FDA expert panel lines up 19-to-1 against Pfizer’s osteoarthritis drug tanezumab (Endpoints) (Press)
• The Great Undoing: Which of Trump’s Policies Will Biden Reverse? (KHN 1, 2)

• EU pledges to keep AstraZeneca doses in the bloc for now (Reuters)
• EU leaders agree to step up COVID-19 vaccine production in Europe (Reuters)
• No more vaccine exports until you fulfill your contracts, EU tells AstraZeneca (Reuters)
• Novavax delays EU vaccine supply deal amid production problems (Reuters)
• Moderna plans factory in eastern Germany, FAZ reports (Reuters)
• Moderna delays shipment of about 600,000 COVID-19 vaccine doses to Canada (Reuters)
• Thermo Fisher to work with Pfizer-BioNtech on vaccine production in Italy (Reuters)
• EU clears vaccine sites to boost inoculation drive (Reuters) (EMA)
• EMA advises limited use of Celltrion COVID-19 drug, says benefits still unclear (Reuters) (EMA)
• Japan's Takeda starts regulatory submissions for dengue vaccine in Europe (Reuters)
• Commission welcomes entry into force of EU4Health programme (EC 1, 2)

• Volunteers break rank to raise doubts in trial of Russia's second COVID-19 vaccine (Reuters)
• Air crews, seafarers should be prioritised for COVID-19 vaccines - WHO, ICAO, IMO (Reuters)
• Colombia grants emergency use for J&J coronavirus vaccine (Reuters)
• EU says on track for 70% of adults vaccinated in second quarter (Reuters)
• UK will have vaccine supply to meet targets, minister says (Reuters)
• UK study finds strong immune responses from one dose of Pfizer COVID-19 shot (Reuters)
• Norway keeps AstraZeneca vaccine on hold for another three weeks (Reuters)
• Iran plans to start making Russia's Sputnik V vaccine in April -RIA (Reuters)

• AstraZeneca’s data missteps shows that drug regulation actually works (Quartz)
• EU Council Agrees Compromise Position On Joint Clinical Assessments (Pink Sheet) (Council)
• The pandemic dramatically reduced flu cases. That could backfire. (Politico)
• FDA Approves New indication for Drug to Treat Neurogenic Detrusor Overactivity in Pediatric Patients (FDA)
• Lawmakers are once again eyeing drug prices—and this time, the threat to pharma is real: analysts (Fierce)
• Gilead poaches Amgen exec Flavius Martin to run its R&D as 30-year veteran Bill Lee retires (Fierce)
• EMA begins accelerated review of Gilead’s Trodelvy for triple-negative breast cancer (PMLive)
• Inspectors grounded - a year of innovation (MHRA)

• FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients (FDA)
• FDA Approves First in the World Device to Treat Patients with Congenital Heart Disease (FDA)
• BrainScope debuts concussion-rating algorithm on its handheld device (Fierce)
• Boston Scientific links just approved liver cancer device to improved survival (MedtechDive)
• Stryker, Zimmer make data and analytics a top priority as robotic procedures ramp up (MedtechDive)

• Fed. Circ. Denies Another Stanford Genetics Patent Over Alice (Law360)
• PTAB To Review University Of Calif. Ocular Blade Patent (Law360)
• Mitsubishi Beats Bid To Invalidate Diabetes Drug Patents (Law360)
• Cherokees Can't Widen Opioid Discovery, Companies Say (Law360)
• Hologic Tells Justices Assignor Estoppel Is Settled Law (Law360)